Výsledky vyhledávání - "Aleksandra Zemla-Brown"

Abstract CT114: Data from first-in-human study of EXS21546, an A2A receptor antagonist, now progressing into phase 1 in RCC/NSCLC

Autor: Nieves Diaz, Holly Garratt, Aleksandra Zemla-Brown, Maria Dominguez, Eric Helmer, Isabella Alt, Robert Sehlke, Norbert Hieger, Thomas Winkler-Penz, Christophe Boudesco, Gregory Vladimer, Tom Wilde, Philip Evans, Antoine Italiano, Michael Krams

Publikováno v: Cancer Research. 83:CT114-CT114

Background: EXS21546 (discovered in collaboration with Evotec) is a clinical stage A2AR selective antagonist with high potential in cancer immunotherapy as a combination agent. A completed healthy volunteer (HV) first-in-human (FIH) study is now bein

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::9c6343da98243e741a479fc314908521
https://doi.org/10.1158/1538-7445.am2023-ct114

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání